Healthcare Sector Stocks
The Healthcare sector has a total of 1047 stocks, with a combined market cap of $9.21 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.17.
Market Cap
9.21T
Revenue
4.67T
Profits
191.11B
PE Ratio
48.17
Profit Margin
4.10%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | 3.41% | 1,228,308 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 627.03B | 2.12% | 2,173,663 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 483.17B | 2.52% | 2,257,185 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 353.42B | 0.92% | 2,362,222 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 341.28B | 1.04% | 1,962,195 | 450.53B |
| 6 | NVS | Novartis AG | 279.37B | 2.09% | 1,065,229 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.14B | 1.55% | 971,930 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 246.11B | 1.38% | 862,347 | 46.34B |
| 9 | AMGN | Amgen Inc. | 223.38B | 2.63% | 987,986 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 183.10B | 2.39% | 1,697,757 | 30.46B |
| 11 | NVO | Novo Nordisk A/S | 171.19B | 1.85% | 8,710,445 | 50.34B |
| 12 | ABT | Abbott Laboratories | 171.00B | 0.67% | 3,097,079 | 46.59B |
| 13 | PFE | Pfizer Inc. | 160.05B | 2.11% | 11,746,314 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.58B | 1.33% | 1,887,744 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 146.42B | 2.40% | 749,603 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.74B | 1.12% | 265,348 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.95B | 0.18% | 5,214,455 | 49.19B |
| 18 | CVS | CVS Health Corporation | 114.11B | 3.23% | 3,452,490 | 412.65B |
| 19 | MDT | Medtronic plc | 110.89B | -0.46% | 21,539,848 | 37.54B |
| 20 | SYK | Stryker Corporation | 106.77B | 0.06% | 875,154 | 25.84B |
| 21 | MCK | McKesson Corporation | 106.76B | -0.65% | 347,178 | 410.98B |
| 22 | SNY | Sanofi | 97.48B | 1.24% | 1,025,363 | 55.89B |
| 23 | GSK | GSK plc | 95.14B | 1.27% | 4,336,980 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 95.13B | 1.66% | 371,152 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.83B | 1.22% | 220,860 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 76.41B | 2.10% | 7,815,477 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 74.58B | 1.10% | 267,058 | 15.53B |
| 28 | CI | The Cigna Group | 73.98B | 2.05% | 510,554 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 61.17B | 0.05% | 7,311,878 | 21.00B |
| 30 | COR | Cencora, Inc. | 60.98B | 1.00% | 317,903 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.24B | 1.71% | 1,515,705 | 28.42B |
| 32 | ARGX | argenx SE | 58.72B | 0.04% | 129,407 | 5.32B |
| 33 | NTRA | Natera, Inc. | 57.60B | -0.27% | 1,885,431 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 53.81B | -0.45% | 325,671 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 49.92B | 0.15% | 1,015,531 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.49B | 0.77% | 699,574 | 22.48B |
| 37 | HUM | Humana Inc. | 48.46B | -0.17% | 1,010,440 | 145.68B |
| 38 | A | Agilent Technologies, Inc. | 47.81B | 0.15% | 1,063,596 | 7.37B |
| 39 | MDLN | Medline Inc. | 47.00B | 0.56% | 1,900,105 | 29.94B |
| 40 | VEEV | Veeva Systems Inc. | 46.11B | 0.46% | 390,912 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.40B | -0.43% | 1,337,233 | 17.32B |
| 42 | RVMD | Revolution Medicines, Inc. | 43.18B | 0.81% | 591,534 | - |
| 43 | WAT | Waters Corporation | 42.96B | 0.18% | 317,714 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 42.68B | -0.26% | 525,049 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 41.40B | 0.36% | 67,682 | 6.13B |
| 46 | ILMN | Illumina, Inc. | 41.21B | -0.23% | 1,399,963 | 4.49B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 40.17B | -1.06% | 288,029 | 4.55B |
| 48 | HLN | Haleon plc | 39.96B | 2.25% | 12,353,792 | 14.80B |
| 49 | BIIB | Biogen Inc. | 33.20B | 0.80% | 504,481 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 32.76B | 0.96% | 1,242,626 | 2.54B |
| 51 | CNC | Centene Corporation | 32.17B | 0.80% | 1,219,744 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.10B | 3.42% | 400,505 | 5.65B |
| 53 | DXCM | DexCom, Inc. | 31.90B | 1.37% | 999,287 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 30.76B | 0.13% | 97,242 | 4.13B |
| 55 | ALC | Alcon Inc. | 30.74B | 0.27% | 743,956 | 10.86B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.50B | 1.77% | 363,336 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 29.56B | 0.29% | 1,765,646 | 9.53B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.29B | 0.12% | 1,048,492 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.17B | -0.20% | 127,518 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 25.42B | 0.57% | 178,264 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.40B | -1.04% | 2,252,004 | 7.53M |
| 62 | DGX | Quest Diagnostics Incorporated | 25.19B | -0.05% | 332,635 | 11.56B |
| 63 | BNTX | BioNTech SE | 24.24B | 0.80% | 369,457 | 3.03B |
| 64 | PHG | Koninklijke Philips N.V. | 23.74B | - | 540,057 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 23.42B | 0.82% | 304,937 | 3.15B |
| 66 | INCY | Incyte Corporation | 23.12B | 1.18% | 539,628 | 5.82B |
| 67 | INSM | Insmed Incorporated | 22.59B | -1.68% | 950,558 | 1.14B |
| 68 | GH | Guardant Health, Inc. | 22.51B | -1.72% | 964,717 | 1.18B |
| 69 | GMAB | Genmab A/S | 21.80B | -2.01% | 2,120,577 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.98B | 0.79% | 152,529 | 21.81B |
| 71 | STE | STERIS plc | 20.62B | 1.38% | 186,213 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.23B | 0.40% | 2,549,470 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.36B | 1.47% | 1,070,950 | 2.91B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 17.06B | -0.25% | 561,470 | 8.51B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.02B | 1.15% | 85,120 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.19B | 1.12% | 204,463 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 14.83B | -0.11% | 369,680 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.75B | -0.47% | 256,504 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.72B | -0.45% | 293,191 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.55B | 0.67% | 841,697 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 14.46B | 4.48% | 5,414,822 | - |
| 82 | CRL | Charles River Laboratories International, Inc. | 14.40B | -1.10% | 526,236 | 4.00B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.39B | 0.80% | 613,216 | 14.37B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.10B | 0.06% | 861,315 | 713.07M |
| 85 | CORT | Corcept Therapeutics Incorporated | 13.02B | 0.73% | 246,158 | 830.81M |
| 86 | TEM | Tempus AI, Inc. | 12.77B | -1.65% | 6,429,802 | 1.43B |
| 87 | ICLR | ICON Public Limited Company | 12.69B | 1.73% | 421,603 | 8.29B |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.67B | 1.74% | 1,153,668 | 1.66B |
| 89 | BAX | Baxter International Inc. | 12.52B | -0.62% | 1,825,404 | 11.47B |
| 90 | PEN | Penumbra, Inc. | 12.50B | 0.13% | 142,704 | 1.50B |
| 91 | EHC | Encompass Health Corporation | 12.10B | -1.62% | 333,501 | 6.21B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.55B | 0.74% | 71,821 | 1.28B |
| 93 | DVA | DaVita Inc. | 11.45B | -0.49% | 267,047 | 14.01B |
| 94 | SNN | Smith & Nephew plc | 11.43B | 0.93% | 544,163 | 6.30B |
| 95 | TECH | Bio-Techne Corporation | 11.37B | 0.10% | 1,507,196 | 1.22B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.23B | - | 1,173,516 | 5.02B |
| 97 | FMS | Fresenius Medical Care AG | 11.15B | -7.05% | 2,260,263 | 22.19B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | -1.74% | 728,612 | 3.41B |
| 99 | COO | The Cooper Companies, Inc. | 10.53B | -1.90% | 1,052,831 | 4.24B |
| 100 | AVTR | Avantor, Inc. | 10.44B | - | 2,997,297 | 6.56B |
| 101 | UHS | Universal Health Services, Inc. | 10.34B | -0.89% | 190,052 | 18.11B |
| 102 | IBRX | ImmunityBio, Inc. | 10.30B | 0.26% | 6,709,839 | 165.79M |
| 103 | GMED | Globus Medical, Inc. | 10.27B | 0.10% | 548,842 | 3.14B |
| 104 | MOH | Molina Healthcare, Inc. | 10.23B | 0.63% | 145,584 | 42.47B |
| 105 | RDY | Dr. Reddy's Laboratories Limited | 10.23B | -1.56% | 1,624,379 | 3.50B |
| 106 | GKOS | Glaukos Corporation | 10.22B | 7.26% | 600,368 | 612.84M |
| 107 | OSCR | Oscar Health, Inc. | 10.19B | 2.16% | 1,442,736 | 15.32B |
| 108 | TXG | 10x Genomics, Inc. | 10.09B | -4.04% | 5,893,137 | 616.91M |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 9.98B | 1.20% | 98,616 | 2.59B |
| 110 | TWST | Twist Bioscience Corporation | 9.97B | -4.77% | 3,433,997 | 431.80M |
| 111 | ALGN | Align Technology, Inc. | 9.95B | -0.98% | 196,070 | 4.14B |
| 112 | PCVX | Vaxcyte, Inc. | 9.92B | -0.07% | 7,558,590 | - |
| 113 | ENSG | The Ensign Group, Inc. | 9.84B | -0.99% | 178,262 | 5.49B |
| 114 | RGEN | Repligen Corporation | 9.69B | -1.85% | 565,067 | 785.10M |
| 115 | KRYS | Krystal Biotech, Inc. | 9.65B | -0.26% | 159,980 | 440.48M |
| 116 | PODD | Insulet Corporation | 9.50B | 1.66% | 384,762 | 3.05B |
| 117 | QGEN | Qiagen N.V. | 9.36B | -0.85% | 1,529,784 | 2.10B |
| 118 | HSIC | Henry Schein, Inc. | 9.34B | -1.21% | 378,321 | 13.60B |
| 119 | AXSM | Axsome Therapeutics, Inc. | 9.26B | 1.42% | 243,833 | 776.57M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.24B | 2.94% | 390,156 | 281.99M |
| 121 | BRKR | Bruker Corporation | 9.17B | -0.55% | 1,737,602 | 3.50B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 9.03B | 2.52% | 402,836 | 105.00M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.69B | -0.07% | 713,452 | 669.50M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.57B | 0.44% | 1,121,482 | 67.67M |
| 125 | HNGE | Hinge Health, Inc. | 7.97B | 0.46% | 352,378 | 720.06M |
| 126 | ABVX | ABIVAX Société Anonyme | 7.84B | -0.80% | 871,177 | 5.33M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 7.81B | -0.13% | 210,992 | 7.46M |
| 128 | ATR | AptarGroup, Inc. | 7.70B | 0.69% | 181,780 | 3.93B |
| 129 | CAI | Caris Life Sciences, Inc. | 7.66B | -1.26% | 2,338,551 | 989.61M |
| 130 | HQY | HealthEquity, Inc. | 7.66B | 1.70% | 274,933 | 1.36B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.59B | 2.59% | 573,127 | 799.54M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.31B | -0.07% | 453,829 | 874.09M |
| 133 | SYRE | Spyre Therapeutics, Inc. | 7.15B | 1.29% | 1,033,317 | - |
| 134 | ALKS | Alkermes plc | 7.00B | 0.19% | 904,537 | 1.67B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.96B | -1.60% | 1,178,135 | 3.12B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.89B | 0.24% | 2,928,218 | 2.58B |
| 137 | PACS | PACS Group, Inc. | 6.86B | 1.20% | 247,089 | 5.55B |
| 138 | IMVT | Immunovant, Inc. | 6.76B | 1.99% | 568,753 | - |
| 139 | GRFS | Grifols, S.A. | 6.68B | 0.27% | 133,875 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.54B | -1.49% | 54,835 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.19% | 235,319 | 1.56B |
| 142 | BLTE | Belite Bio, Inc | 6.24B | -0.39% | 41,888 | - |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | -0.61% | 218,498 | 239.92M |
| 144 | BLCO | Bausch + Lomb Corporation | 6.19B | 0.87% | 84,156 | 5.32B |
| 145 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.17B | 2.62% | 125,839 | 840.85M |
| 146 | GRAL | GRAIL, Inc. | 5.95B | -2.99% | 513,289 | 165.26M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.94B | 0.41% | 73,257 | 290.54M |
| 148 | IOVA | Iovance Biotherapeutics, Inc. | 5.88B | 0.15% | 8,136,245 | 324.97M |
| 149 | KOD | Kodiak Sciences Inc. | 5.75B | -0.66% | 575,170 | - |
| 150 | CGON | CG Oncology, Inc. | 5.63B | -0.24% | 193,175 | 6.23M |
| 151 | RDNT | RadNet, Inc. | 5.49B | -0.65% | 91,239 | 2.27B |
| 152 | MMED | MiniMed Group, Inc. | 5.43B | -1.68% | 4,273,289 | 3.22B |
| 153 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | 3.71% | 475,163 | 618.07M |
| 154 | ORKA | Oruka Therapeutics, Inc. | 5.32B | 0.22% | 427,083 | - |
| 155 | STVN | Stevanato Group S.p.A. | 5.31B | -2.11% | 134,272 | 1.40B |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.30B | 2.61% | 688,746 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.30B | -0.33% | 353,676 | 1.01B |
| 158 | TFX | Teleflex Incorporated | 5.28B | -0.01% | 198,454 | 2.25B |
| 159 | COGT | Cogent Biosciences, Inc. | 5.26B | -0.16% | 514,588 | - |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.23B | -0.96% | 397,982 | 591.33M |
| 161 | CRSP | CRISPR Therapeutics AG | 5.17B | -0.96% | 720,817 | 13.39M |
| 162 | SHC | Sotera Health Company | 5.15B | -1.04% | 452,567 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.10B | 0.61% | 135,692 | 1.58B |
| 164 | ERAS | Erasca, Inc. | 5.04B | 0.70% | 1,461,048 | - |
| 165 | DOCS | Doximity, Inc. | 4.97B | 0.23% | 1,015,070 | 655.57M |
| 166 | WAY | Waystar Holding Corp. | 4.93B | -2.54% | 710,911 | 1.21B |
| 167 | DFTX | Definium Therapeutics, Inc. | 4.82B | 0.73% | 718,107 | - |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 4.82B | 0.82% | 177,345 | 1.90M |
| 169 | HAE | Haemonetics Corporation | 4.72B | 0.22% | 122,793 | 1.35B |
| 170 | MANE | Veradermics, Incorporated | 4.68B | 2.81% | 342,210 | - |
| 171 | LFST | LifeStance Health Group, Inc. | 4.68B | 0.99% | 671,219 | 1.58B |
| 172 | CON | Concentra Group Holdings Parent, Inc. | 4.66B | 0.36% | 297,034 | 2.29B |
| 173 | OPCH | Option Care Health, Inc. | 4.65B | 0.10% | 9,058,386 | 5.69B |
| 174 | BLLN | BillionToOne, Inc. | 4.54B | -3.69% | 480,123 | 397.41M |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.35B | 0.02% | 490,291 | - |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | 0.06% | 110,221 | 1.84B |
| 177 | HTFL | HeartFlow, Inc. | 4.29B | -2.66% | 570,641 | 212.07M |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.28B | 1.00% | 286,055 | 1.33B |
| 179 | ABCL | AbCellera Biologics Inc. | 4.25B | -0.15% | 3,122,424 | 66.17M |
| 180 | ADPT | Adaptive Biotechnologies Corporation | 4.19B | -2.38% | 1,125,945 | 308.08M |
| 181 | LIVN | LivaNova PLC | 4.18B | 1.35% | 217,812 | 1.47B |
| 182 | ICUI | ICU Medical, Inc. | 3.98B | -0.42% | 51,957 | 2.16B |
| 183 | RLAY | Relay Therapeutics, Inc. | 3.94B | -4.06% | 1,116,313 | 10.35M |
| 184 | TLX | Telix Pharmaceuticals Limited | 3.85B | 2.64% | 174,763 | 890.79M |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.73B | 0.91% | 1,239,855 | 53.81M |
| 186 | NVST | Envista Holdings Corporation | 3.71B | -0.69% | 654,599 | 2.86B |
| 187 | LEGN | Legend Biotech Corporation | 3.70B | 2.03% | 523,415 | 1.27B |
| 188 | OGN | Organon & Co. | 3.61B | 0.04% | 763,176 | 6.13B |
| 189 | PBLS | Parabilis Medicines, Inc. | 3.56B | -0.10% | 484,352 | 148.00K |
| 190 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | 0.38% | 167,208 | 234.13M |
| 191 | NHC | National HealthCare Corporation | 3.54B | -1.06% | 37,980 | 1.56B |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.53B | 0.36% | 621,696 | -665.00K |
| 193 | CELC | Celcuity Inc. | 3.53B | 1.16% | 414,739 | - |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.52B | -0.66% | 870,241 | 7.50M |
| 195 | RGC | Regencell Bioscience Holdings Limited | 3.52B | -3.40% | 80,755 | - |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.51B | -0.64% | 161,084 | 825.34M |
| 197 | VCYT | Veracyte, Inc. | 3.47B | -3.43% | 565,242 | 561.90M |
| 198 | PLSE | Pulse Biosciences, Inc. | 3.45B | -2.67% | 99,902 | 1.19M |
| 199 | ACAD | Acadia Pharmaceuticals Inc. | 3.38B | -0.63% | 420,697 | 1.14B |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.36B | 1.41% | 2,844,674 | - |
| 201 | CDNA | CareDx, Inc. | 3.32B | 0.49% | 826,584 | 458.09M |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 0.42% | 114,243 | 606.33M |
| 203 | WRBY | Warby Parker Inc. | 3.15B | -2.86% | 531,741 | 911.61M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.12B | 1.07% | 348,890 | 117.00M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.07B | -0.26% | 525,154 | 3.60M |
| 206 | ELVN | Enliven Therapeutics, Inc. | 3.06B | -1.60% | 291,011 | - |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | 0.96% | 762,178 | 463.98M |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.99B | 4.09% | 957,289 | - |
| 209 | TMDX | TransMedics Group, Inc. | 2.90B | 4.16% | 377,775 | 668.47M |
| 210 | ZLAB | Zai Lab Limited | 2.84B | -1.02% | 104,391 | 449.61M |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 2.75B | 1.72% | 519,386 | 3.37B |
| 212 | PGEN | Precigen, Inc. | 2.73B | 1.06% | 1,397,216 | 85.72M |
| 213 | ATRC | AtriCure, Inc. | 2.73B | -0.04% | 231,166 | 569.62M |
| 214 | NAMS | NewAmsterdam Pharma Company N.V. | 2.69B | 1.17% | 745,725 | 7.12M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.68B | 0.53% | 1,177,348 | 2.60B |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.62B | 0.41% | 89,514 | 1.46B |
| 217 | MBX | MBX Biosciences, Inc. | 2.61B | -4.66% | 179,783 | - |
| 218 | PRVA | Privia Health Group, Inc. | 2.60B | 0.54% | 311,737 | 2.36B |
| 219 | BKD | Brookdale Senior Living Inc. | 2.60B | -0.18% | 1,435,521 | 2.93B |
| 220 | NEOG | Neogen Corporation | 2.52B | -3.34% | 7,099,128 | 884.00M |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.51B | 0.82% | 101,397 | 830.44M |
| 222 | CLOV | Clover Health Investments, Corp. | 2.50B | 2.39% | 1,300,360 | 2.48B |
| 223 | HCM | HUTCHMED (China) Limited | 2.50B | -2.05% | 51,567 | 549.12M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.47B | -2.22% | 1,022,093 | 156.04M |
| 225 | CLDX | Celldex Therapeutics, Inc. | 2.41B | -0.92% | 554,532 | 158.00K |
| 226 | LQDA | Liquidia Corporation | 2.38B | 2.62% | 3,187,316 | 450.91M |
| 227 | IRON | Disc Medicine, Inc. | 2.37B | 0.34% | 162,771 | - |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.37B | 1.24% | 464,921 | 36.77M |
| 229 | BHC | Bausch Health Companies Inc. | 2.34B | 3.82% | 979,873 | 10.85B |
| 230 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | -6.37% | 25,167,133 | 54.86M |
| 231 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 0.95% | 177,387 | 959.90M |
| 232 | ADMA | ADMA Biologics, Inc. | 2.30B | 0.88% | 1,009,180 | 512.28M |
| 233 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -0.09% | 1,903,374 | - |
| 234 | UFPT | UFP Technologies, Inc. | 2.28B | -2.69% | 57,969 | 631.64M |
| 235 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | 1.53% | 123,625 | 1.10B |
| 236 | PHVS | Pharvaris N.V. | 2.23B | 1.93% | 191,889 | - |
| 237 | IMNM | Immunome, Inc. | 2.20B | 0.16% | 371,958 | 4.02M |
| 238 | BFLY | Butterfly Network, Inc. | 2.19B | -5.29% | 3,186,749 | 112.14M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.16B | 1.80% | 1,143,415 | - |
| 240 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 2.29% | 226,357 | 311.51M |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | 5.03% | 2,001,131 | 940.61M |
| 242 | PGNY | Progyny, Inc. | 2.13B | 7.02% | 963,052 | 1.31B |
| 243 | ALVO | Alvotech | 2.12B | -3.26% | 438,981 | 494.61M |
| 244 | AXGN | Axogen, Inc. | 2.12B | -0.63% | 491,798 | 251.17M |
| 245 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 2.03% | 711,943 | 71.13M |
| 246 | ADUS | Addus HomeCare Corporation | 2.10B | 1.43% | 97,464 | 1.48B |
| 247 | VCEL | Vericel Corporation | 2.09B | 1.70% | 162,758 | 306.30M |
| 248 | WGS | GeneDx Holdings Corp. | 2.08B | -2.36% | 205,838 | 454.43M |
| 249 | MD | Pediatrix Medical Group, Inc. | 2.08B | 0.81% | 243,571 | 1.95B |
| 250 | TRLV | Trulieve Cannabis Corp. | 2.08B | 1.31% | 513,918 | 1.14B |
| 251 | NEO | NeoGenomics, Inc. | 2.06B | -2.91% | 1,405,010 | 766.30M |
| 252 | ALMR | Alamar Biosciences, Inc. | 2.05B | -8.56% | 556,831 | 100.42M |
| 253 | SDGR | Schrödinger, Inc. | 2.03B | -6.09% | 2,254,575 | 259.04M |
| 254 | URGN | UroGen Pharma Ltd. | 2.02B | -0.02% | 145,884 | 188.73M |
| 255 | ADRX | ADARx Pharmaceuticals, Inc. | 2.02B | -3.20% | 284,672 | 6.13M |
| 256 | PRGO | Perrigo Company plc | 1.99B | 2.64% | 794,867 | 4.14B |
| 257 | FTRE | Fortrea Holdings Inc. | 1.98B | 0.19% | 485,525 | 2.68B |
| 258 | VIR | Vir Biotechnology, Inc. | 1.96B | 0.09% | 1,088,326 | 303.23M |
| 259 | MLYS | Mineralys Therapeutics, Inc. | 1.96B | 1.05% | 346,284 | - |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 1.60% | 103,588 | 1.13B |
| 261 | GPCR | Structure Therapeutics Inc. | 1.96B | -0.11% | 575,321 | - |
| 262 | INSP | Inspire Medical Systems, Inc. | 1.95B | -1.10% | 182,761 | 898.74M |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.95B | -0.02% | 139,006 | 245.82M |
| 264 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | -5.35% | 1,635,226 | 208.78M |
| 265 | ASTH | Astrana Health, Inc. | 1.91B | 0.88% | 93,198 | 3.84B |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | 0.54% | 545,478 | 98.34M |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.90B | 0.99% | 1,354,223 | - |
| 268 | ZYME | Zymeworks Inc. | 1.89B | 3.98% | 371,008 | 37.13M |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.88B | 1.80% | 77,113 | - |
| 270 | XERS | Xeris Biopharma Holdings, Inc. | 1.87B | 1.74% | 823,505 | 335.41M |
| 271 | NVAX | Novavax, Inc. | 1.86B | -0.35% | 4,902,280 | 413.80M |
| 272 | MESO | Mesoblast Limited | 1.86B | 2.87% | 111,684 | 120.25M |
| 273 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 1.33% | 796,496 | 1.97B |
| 274 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 5.20% | 153,687 | 1.00M |
| 275 | XNCR | Xencor, Inc. | 1.83B | 0.86% | 254,379 | 104.97M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.83B | 0.99% | 66,076 | 262.43M |
| 277 | BHVN | Biohaven Ltd. | 1.82B | -0.33% | 580,251 | - |
| 278 | ALHC | Alignment Healthcare, Inc. | 1.81B | 4.00% | 1,912,908 | 4.58B |
| 279 | SGRY | Surgery Partners, Inc. | 1.79B | 3.06% | 854,534 | 3.37B |
| 280 | GENB | Generate Biomedicines, Inc. | 1.76B | -0.51% | 432,191 | 26.48M |
| 281 | SNDA | Sonida Senior Living, Inc. | 1.75B | -0.32% | 177,377 | 481.07M |
| 282 | FRNM | Freenome, Inc. | 1.75B | -0.37% | 143,359 | 35.41M |
| 283 | NVCR | NovoCure Limited | 1.73B | -0.60% | 446,466 | 699.19M |
| 284 | SEPN | Septerna, Inc. | 1.72B | 3.11% | 186,818 | 98.88M |
| 285 | PSNL | Personalis, Inc. | 1.71B | 0.12% | 2,839,088 | 69.67M |
| 286 | NUVB | Nuvation Bio Inc. | 1.70B | -0.61% | 1,590,785 | 169.90M |
| 287 | NTLA | Intellia Therapeutics, Inc. | 1.69B | -2.59% | 2,449,638 | 59.51M |
| 288 | XRAY | DENTSPLY SIRONA Inc. | 1.69B | -0.70% | 1,505,287 | 3.64B |
| 289 | OCUL | Ocular Therapeutix, Inc. | 1.66B | 2.72% | 1,636,532 | 52.06M |
| 290 | ATEC | Alphatec Holdings, Inc. | 1.63B | 0.19% | 742,403 | 815.05M |
| 291 | OMCL | Omnicell, Inc. | 1.63B | 0.76% | 190,828 | 1.25B |
| 292 | CMPS | COMPASS Pathways plc | 1.63B | 1.64% | 721,052 | - |
| 293 | AZTA | Azenta, Inc. | 1.61B | -6.53% | 828,739 | 613.81M |
| 294 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | -0.22% | 79,020 | 106.73M |
| 295 | ABSI | Absci Corporation | 1.61B | -8.86% | 2,615,560 | 1.56M |
| 296 | QURE | uniQure N.V. | 1.59B | -0.43% | 580,195 | 18.67M |
| 297 | STOK | Stoke Therapeutics, Inc. | 1.58B | 0.78% | 145,955 | 27.59M |
| 298 | ETON | Eton Pharmaceuticals, Inc. | 1.58B | 1.15% | 212,688 | 105.60M |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | 1.61% | 338,033 | 252.25M |
| 300 | BRVE | Braveheart Bio, Inc. | 1.55B | -3.84% | 171,713 | - |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 0.84% | 102,411 | 978.38M |
| 302 | ARDT | Ardent Health, Inc. | 1.54B | 1.97% | 146,937 | 6.41B |
| 303 | PAHC | Phibro Animal Health Corporation | 1.53B | 2.98% | 66,949 | 1.52B |
| 304 | IMCR | Immunocore Holdings plc | 1.52B | -0.27% | 50,682 | 430.78M |
| 305 | INVA | Innoviva, Inc. | 1.51B | 0.67% | 174,707 | 440.00M |
| 306 | RAPP | Rapport Therapeutics, Inc. | 1.49B | -0.18% | 155,166 | 20.00M |
| 307 | NUTX | Nutex Health Inc. | 1.48B | -0.92% | 92,631 | 846.72M |
| 308 | GHRS | GH Research PLC | 1.48B | -0.14% | 110,618 | - |
| 309 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | 2.97% | 2,198,979 | 717.00M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.78% | 204,716 | 20.00M |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.45B | 0.28% | 186,839 | 1.86B |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.45B | 0.41% | 26,579 | - |
| 313 | AGL | agilon health, inc. | 1.44B | 2.95% | 65,840 | 5.92B |
| 314 | TSHA | Taysha Gene Therapies, Inc. | 1.43B | 0.11% | 871,214 | 5.49M |
| 315 | KLRA | Kailera Therapeutics, Inc. | 1.42B | 1.29% | 381,956 | - |
| 316 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 2.21% | 67,770 | 1.30M |
| 317 | AMN | AMN Healthcare Services, Inc. | 1.40B | -1.44% | 152,661 | 3.43B |
| 318 | PNTG | The Pennant Group, Inc. | 1.40B | 0.11% | 372,721 | 1.10B |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.39B | 0.15% | 116,820 | - |
| 320 | CERT | Certara, Inc. | 1.39B | -1.83% | 1,255,359 | 421.75M |
| 321 | ANAB | AnaptysBio, Inc. | 1.39B | -3.07% | 256,637 | 106.09M |
| 322 | OMER | Omeros Corporation | 1.36B | 1.30% | 226,547 | 38.42M |
| 323 | NKTR | Nektar Therapeutics | 1.34B | -1.62% | 528,057 | 54.59M |
| 324 | CNMD | CONMED Corporation | 1.33B | -0.18% | 109,273 | 1.37B |
| 325 | COAG | Hemab Therapeutics Holdings, Inc. | 1.33B | 0.21% | 203,057 | - |
| 326 | KARD | Kardigan, Inc. | 1.31B | 4.15% | 567,838 | - |
| 327 | DRTS | Alpha Tau Medical Ltd. | 1.31B | -2.00% | 193,375 | - |
| 328 | OMDA | Omada Health, Inc. | 1.30B | 2.22% | 288,113 | 309.76M |
| 329 | AAPG | Ascentage Pharma Group International | 1.29B | -4.97% | 5,552 | 94.61M |
| 330 | SVRA | Savara Inc. | 1.28B | 8.06% | 1,419,673 | - |
| 331 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 2.50% | 263,118 | - |
| 332 | NBTX | Nanobiotix S.A. | 1.26B | -2.10% | 88,378 | 13.15M |
| 333 | REPL | Replimune Group, Inc. | 1.26B | 0.91% | 561,715 | - |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 0.12% | 135,059 | 804.27M |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.25B | 3.38% | 225,736 | - |
| 336 | INNV | InnovAge Holding Corp. | 1.25B | 1.44% | 81,219 | 989.71M |
| 337 | CRON | Cronos Group Inc. | 1.21B | -0.30% | 202,461 | 179.09M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.15B | 1.59% | 63,302 | - |
| 339 | HROW | Harrow, Inc. | 1.14B | 0.40% | 230,736 | 275.59M |
| 340 | STAA | STAAR Surgical Company | 1.13B | 2.17% | 276,693 | 339.59M |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.13B | 0.37% | 662,577 | 1.04B |
| 342 | LBRX | LB Pharmaceuticals Inc | 1.13B | 1.96% | 239,386 | - |
| 343 | GDRX | GoodRx Holdings, Inc. | 1.12B | 0.31% | 224,034 | 785.23M |
| 344 | TRAX | First Tracks Biotherapeutics, Inc. | 1.12B | -0.51% | 143,864 | - |
| 345 | BCAX | Bicara Therapeutics Inc. | 1.11B | 1.15% | 347,229 | - |
| 346 | MNKD | MannKind Corporation | 1.10B | -7.82% | 3,003,242 | 393.63M |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | -0.29% | 166,755 | 730.02M |
| 348 | IRMD | IRADIMED CORPORATION | 1.09B | 0.94% | 48,407 | 86.34M |
| 349 | BVS | Bioventus Inc. | 1.09B | -0.69% | 134,485 | 581.85M |
| 350 | VOR | Vor Biopharma Inc. | 1.09B | 0.98% | 180,505 | - |
| 351 | JANX | Janux Therapeutics, Inc. | 1.09B | 6.08% | 390,564 | 24.00M |
| 352 | AORT | Artivion, Inc. | 1.07B | 0.92% | 73,342 | 471.47M |
| 353 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | 5.11% | 435,966 | 337.34M |
| 354 | MGTX | MeiraGTx Holdings plc | 1.05B | 3.21% | 307,019 | 397.50M |
| 355 | AHG | Akso Health Group | 1.05B | 4.27% | 8,924 | 13.83M |
| 356 | CGEM | Cullinan Therapeutics, Inc. | 1.04B | -0.31% | 271,949 | - |
| 357 | OPK | OPKO Health, Inc. | 1.04B | -4.79% | 1,056,622 | 587.90M |
| 358 | ENOV | Enovis Corporation | 1.03B | -1.54% | 324,433 | 2.30B |
| 359 | IMTX | Immatics N.V. | 1.03B | 0.67% | 473,676 | 47.65M |
| 360 | IART | Integra LifeSciences Holdings Corporation | 1.03B | -0.60% | 425,952 | 1.65B |
| 361 | PCRX | Pacira BioSciences, Inc. | 1.03B | 4.24% | 251,495 | 746.16M |
| 362 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | -4.67% | 48,034 | - |
| 363 | CSTL | Castle Biosciences, Inc. | 1.03B | 0.81% | 101,939 | 357.28M |
| 364 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | -0.56% | 35,744 | 1.04B |
| 365 | TDOC | Teladoc Health, Inc. | 1.01B | -3.47% | 1,500,545 | 2.49B |
| 366 | AKTS | Aktis Oncology, Inc. | 1.01B | 1.62% | 149,278 | 10.06M |
| 367 | HSTM | HealthStream, Inc. | 989.78M | 3.32% | 96,072 | 321.12M |
| 368 | BBNX | Beta Bionics, Inc. | 972.82M | -0.81% | 226,639 | 119.01M |
| 369 | KURA | Kura Oncology, Inc. | 965.22M | 3.04% | 517,400 | 77.23M |
| 370 | SPTX | Seaport Therapeutics, Inc. | 953.11M | 2.50% | 89,741 | - |
| 371 | MLTX | MoonLake Immunotherapeutics | 950.64M | 2.01% | 604,272 | - |
| 372 | ANL | Adlai Nortye Group Ltd. | 944.40M | 1.42% | 53,100 | 18.06M |
| 373 | ANRO | Alto Neuroscience, Inc. | 941.03M | 1.22% | 120,187 | - |
| 374 | CBLL | CeriBell, Inc. | 919.16M | -1.60% | 133,156 | 101.96M |
| 375 | RIGL | Rigel Pharmaceuticals, Inc. | 888.13M | 3.11% | 76,727 | 276.79M |
| 376 | GLUE | Monte Rosa Therapeutics, Inc. | 888.11M | 5.47% | 833,799 | 28.73M |
| 377 | CRVS | Corvus Pharmaceuticals, Inc. | 883.27M | -0.57% | 554,786 | - |
| 378 | ODTX | Odyssey Therapeutics, Inc. | 881.70M | 1.49% | 134,238 | 99.00K |
| 379 | ALMS | Alumis Inc. | 878.87M | -2.02% | 552,996 | 7.40M |
| 380 | JBIO | Jade Biosciences, Inc. | 864.29M | 1.34% | 219,432 | - |
| 381 | ABUS | Arbutus Biopharma Corporation | 859.65M | -3.01% | 1,293,243 | 181.72M |
| 382 | SIBN | SI-BONE, Inc. | 859.62M | -1.89% | 154,235 | 213.60M |
| 383 | SLBT | SL Science Holding Limited | 858.25M | -0.99% | 50,565 | 3.27M |
| 384 | OBX | Obsidian Therapeutics, Inc. | 844.44M | 3.40% | 135,469 | - |
| 385 | QDEL | QuidelOrtho Corporation | 843.48M | -2.15% | 1,018,240 | 2.67B |
| 386 | PACB | Pacific Biosciences of California, Inc. | 840.80M | 0.19% | 10,819,510 | 159.27M |
| 387 | SANA | Sana Biotechnology, Inc. | 823.24M | - | 1,609,225 | - |
| 388 | ARDX | Ardelyx, Inc. | 822.32M | -0.30% | 1,545,346 | 450.89M |
| 389 | SGP | SpyGlass Pharma, Inc. | 806.93M | -2.64% | 15,938 | - |
| 390 | INMD | InMode Ltd. | 805.31M | 0.14% | 252,315 | 374.63M |
| 391 | IMMX | Immix Biopharma, Inc. | 800.01M | 0.10% | 358,650 | - |
| 392 | AVBP | ArriVent BioPharma, Inc. | 798.05M | 7.26% | 1,695,131 | - |
| 393 | AHCO | AdaptHealth Corp. | 796.45M | 3.47% | 803,562 | 3.36B |
| 394 | HELP | Helus Pharma Inc. | 787.59M | 0.19% | 369,092 | - |
| 395 | GMRS | GMR Solutions Inc. | 786.54M | -0.78% | 193,444 | 5.88B |
| 396 | LXRX | Lexicon Pharmaceuticals, Inc. | 785.35M | 0.86% | 465,795 | 41.47M |
| 397 | VREX | Varex Imaging Corporation | 778.26M | -0.08% | 144,105 | 865.00M |
| 398 | DNA | Ginkgo Bioworks Holdings, Inc. | 774.41M | -7.33% | 4,734,326 | 132.42M |
| 399 | GERN | Geron Corporation | 774.18M | -0.41% | 2,467,475 | 204.56M |
| 400 | ANNX | Annexon, Inc. | 771.59M | 0.99% | 851,216 | - |
| 401 | APMD | Apnimed, Inc. | 771.42M | -0.64% | 232,640 | 115.12M |
| 402 | ATTO | Attovia Therapeutics, Inc. | 761.01M | -4.74% | 149,459 | 1.80M |
| 403 | IVA | Inventiva S.A. | 760.69M | -3.61% | 789,923 | 2.81M |
| 404 | CADL | Candel Therapeutics, Inc. | 758.30M | 0.41% | 302,435 | - |
| 405 | VSTM | Verastem, Inc. | 748.51M | 6.65% | 1,426,082 | 87.53M |
| 406 | DSGN | Design Therapeutics, Inc. | 748.48M | -0.08% | 127,839 | - |
| 407 | GYRE | Gyre Therapeutics, Inc. | 747.54M | -0.42% | 41,683 | 109.82M |
| 408 | ACHV | Achieve Life Sciences, Inc. | 745.01M | 2.99% | 409,610 | - |
| 409 | SLDB | Solid Biosciences Inc. | 740.93M | -0.14% | 247,279 | - |
| 410 | AVTX | Avalo Therapeutics, Inc. | 737.41M | 1.18% | 226,631 | 59.00K |
| 411 | OLMA | Olema Pharmaceuticals, Inc. | 719.23M | 3.79% | 371,714 | - |
| 412 | COLL | Collegium Pharmaceutical, Inc. | 715.74M | 0.48% | 185,166 | 808.21M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 705.47M | 1.67% | 248,132 | 92.01M |
| 414 | WVE | Wave Life Sciences, Inc. | 701.49M | 1.14% | 1,165,481 | 65.37M |
| 415 | PHAR | Pharming Group N.V. | 693.87M | 0.33% | 1,213 | 366.48M |
| 416 | CTKB | Cytek Biosciences, Inc. | 685.66M | -1.95% | 764,709 | 206.71M |
| 417 | AVR | Anteris Technologies Global Corp. | 685.38M | -0.28% | 700,937 | 2.24M |
| 418 | PRME | Prime Medicine, Inc. | 681.37M | 9.43% | 6,433,064 | 4.07M |
| 419 | MDXG | MiMedx Group, Inc. | 677.06M | 0.54% | 281,306 | 355.17M |
| 420 | OABI | OmniAb, Inc. | 675.34M | 6.78% | 786,194 | 38.46M |
| 421 | STLN | Starling Oncology, Inc. | 674.68M | 0.61% | 441,359 | 587.24M |
| 422 | FTH | Faeth Therapeutics, Inc. | 673.14M | -3.12% | 127,516 | - |
| 423 | AURA | Aura Biosciences, Inc. | 672.01M | 5.02% | 296,841 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 668.66M | 4.94% | 408,628 | 136.07M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 667.92M | 2.35% | 41,389 | - |
| 426 | PHR | Phreesia, Inc. | 643.37M | 1.12% | 148,104 | 507.79M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 636.17M | 6.06% | 1,133,686 | 389.32M |
| 428 | SGMT | Sagimet Biosciences Inc. | 632.51M | 1.83% | 290,047 | - |
| 429 | CLYM | Climb Bio, Inc. | 621.46M | 1.31% | 356,635 | - |
| 430 | SOPH | SOPHiA GENETICS SA | 615.47M | -2.03% | 204,594 | 86.17M |
| 431 | SLN | Silence Therapeutics plc | 603.30M | 1.93% | 775,678 | 615.00K |
| 432 | KIDS | OrthoPediatrics Corp. | 595.17M | 0.37% | 53,809 | 252.72M |
| 433 | ANGO | AngioDynamics, Inc. | 591.88M | -0.69% | 436,073 | 320.17M |
| 434 | CBIO | Crescent Biopharma, Inc. | 591.51M | 1.84% | 783,084 | 11.88M |
| 435 | WEAV | Weave Communications, Inc. | 590.39M | - | 219,154 | 257.79M |
| 436 | EVO | Evotec SE | 588.29M | - | 72,661 | 819.47M |
| 437 | DBVT | DBV Technologies S.A. | 586.22M | -0.70% | 297,641 | 5.04M |
| 438 | AQST | Aquestive Therapeutics, Inc. | 579.86M | 0.22% | 430,928 | 54.09M |
| 439 | STTK | Shattuck Labs, Inc. | 576.09M | -2.05% | 376,389 | 1.00M |
| 440 | ETRA | Electra Therapeutics, Inc. | 571.18M | -7.33% | 158,157 | - |
| 441 | MNPR | Monopar Therapeutics Inc. | 566.57M | 6.08% | 51,392 | - |
| 442 | CRMD | CorMedix Inc. | 565.88M | -0.27% | 372,847 | 462.25M |
| 443 | CTMX | CytomX Therapeutics, Inc. | 562.18M | 0.78% | 826,188 | 18.30M |
| 444 | FLGT | Fulgent Genetics, Inc. | 558.84M | -1.31% | 93,614 | 323.93M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 554.82M | 3.02% | 837,517 | 239.66M |
| 446 | SSII | SS Innovations International, Inc. | 549.08M | -0.72% | 12,380 | 52.40M |
| 447 | DCTH | Delcath Systems, Inc. | 548.24M | 2.53% | 89,965 | 95.42M |
| 448 | VALN | Valneva SE | 545.18M | -0.51% | 1,707 | 163.30M |
| 449 | MPLT | MapLight Therapeutics, Inc. | 535.75M | -0.52% | 142,737 | - |
| 450 | ALT | Altimmune, Inc. | 530.06M | 2.06% | 1,987,438 | 31.00K |
| 451 | OCS | Oculis Holding AG | 524.72M | -2.52% | 66,857 | 1.45M |
| 452 | ACRS | Aclaris Therapeutics, Inc. | 522.56M | -4.05% | 6,570,070 | 8.22M |
| 453 | BLSM | BlossomHill Therapeutics, Inc. | 522.23M | -4.97% | 112,286 | - |
| 454 | DRUG | Bright Minds Biosciences Inc. | 515.54M | 7.40% | 297,203 | - |
| 455 | TLRY | Tilray Brands, Inc. | 513.03M | -0.93% | 1,407,371 | 915.45M |
| 456 | NGNE | Neurogene Inc. | 511.89M | 0.51% | 57,841 | 925.00K |
| 457 | PBYI | Puma Biotechnology, Inc. | 508.46M | 3.68% | 119,905 | 231.24M |
| 458 | SENS | Senseonics Holdings, Inc. | 507.06M | -3.71% | 242,022 | 48.55M |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 506.33M | -0.78% | 484,130 | - |
| 460 | EOLS | Evolus, Inc. | 506.28M | 3.86% | 194,898 | 316.49M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 462 | RGNX | REGENXBIO Inc. | 503.68M | 2.42% | 398,014 | 174.48M |
| 463 | TCMD | Tactile Systems Technology, Inc. | 502.88M | 0.05% | 72,859 | 350.31M |
| 464 | ALLO | Allogene Therapeutics, Inc. | 500.96M | -0.68% | 1,834,571 | 4.64M |
| 465 | GLAS | Glass House Brands Inc. | 491.00M | 0.97% | 392,172 | 176.98M |
| 466 | MASS | 908 Devices Inc. | 486.91M | -4.46% | 258,026 | 60.84M |
| 467 | ARVN | Arvinas, Inc. | 485.17M | 1.50% | 224,453 | 316.70M |
| 468 | CTNM | Contineum Therapeutics, Inc. | 482.30M | 1.34% | 227,486 | - |
| 469 | PROK | ProKidney Corp. | 479.18M | -0.94% | 286,825 | 818.00K |
| 470 | AUTL | Autolus Therapeutics plc | 476.43M | - | 603,662 | 117.39M |
| 471 | SGHT | Sight Sciences, Inc. | 473.21M | 0.35% | 98,569 | 83.38M |
| 472 | OVID | Ovid Therapeutics Inc. | 468.71M | 1.27% | 562,681 | 1.58M |
| 473 | CERS | Cerus Corporation | 467.54M | -0.85% | 369,667 | 221.55M |
| 474 | ASMB | Assembly Biosciences, Inc. | 466.05M | 3.20% | 57,610 | 74.85M |
| 475 | RZLT | Rezolute, Inc. | 463.64M | 2.31% | 1,042,667 | - |
| 476 | EVH | Evolent Health, Inc. | 462.41M | 6.51% | 1,393,098 | 2.10B |
| 477 | CAPR | Capricor Therapeutics, Inc. | 457.55M | 1.55% | 1,072,808 | 11.13M |
| 478 | BWAY | BrainsWay Ltd. | 457.33M | -1.98% | 79,758 | 60.70M |
| 479 | TKNO | Alpha Teknova, Inc. | 453.67M | -3.43% | 82,898 | 43.70M |
| 480 | NRC | NRC Health | 451.35M | 1.62% | 25,963 | 140.00M |
| 481 | DMAC | DiaMedica Therapeutics Inc. | 449.20M | 2.46% | 90,069 | - |
| 482 | NPCE | NeuroPace, Inc. | 447.25M | 2.84% | 47,565 | 106.99M |
| 483 | TECX | Tectonic Therapeutic, Inc. | 446.70M | 1.96% | 155,037 | - |
| 484 | KMDA | Kamada Ltd. | 443.92M | -2.34% | 28,968 | 191.85M |
| 485 | ENTX | Entera Bio Ltd. | 441.51M | 0.79% | 526,183 | 42.00K |
| 486 | YDES | YD Bio Limited | 439.15M | 0.81% | 77,981 | 1.24M |
| 487 | AGMB | AgomAb Therapeutics NV | 432.40M | -0.68% | 56,446 | - |
| 488 | PRTA | Prothena Corporation plc | 430.72M | 4.61% | 227,191 | 54.53M |
| 489 | EDIT | Editas Medicine, Inc. | 430.02M | 2.56% | 1,474,294 | 47.01M |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | -0.12% | 326,137 | 116.93M |
| 491 | CTEV | Claritev Corporation | 423.43M | 3.72% | 62,718 | 994.67M |
| 492 | SRTA | Strata Critical Medical, Inc. | 414.47M | -1.37% | 256,209 | 255.98M |
| 493 | AVIR | Atea Pharmaceuticals, Inc. | 413.86M | 1.78% | 86,662 | - |
| 494 | ZURA | Zura Bio Limited | 408.23M | 7.58% | 1,253,577 | - |
| 495 | EIKN | Eikon Therapeutics, Inc. | 407.05M | 0.07% | 157,161 | - |
| 496 | MYGN | Myriad Genetics, Inc. | 406.51M | -0.70% | 435,737 | 806.60M |
| 497 | RCEL | AVITA Medical, Inc. | 406.38M | 1.15% | 82,801 | 75.63M |
| 498 | CARL | Carlsmed, Inc. | 401.21M | 0.38% | 10,534 | 63.30M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 398.59M | 1.57% | 220,264 | 22.42M |
| 500 | SI | Shoulder Innovations, Inc. | 395.46M | -0.76% | 18,602 | 60.06M |